Related stocks: Real Estate
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Related stocks: Real Estate
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | TTM 6:1 split | MAY 2025 | MAY 2024 | MAY 2023 | MAY 2022 | MAY 2021 |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | -$0 | $0 | $0 | -$0 |
| General & Administrative | $0 | $0 | $0 | $0 | $0 | $0 |
| Provision for Doubtful Accounts | — | — | — | — | $0 | $0 |
| Total Operating Expenses | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | -$0 | -$0 | -$0 | -$0 | -$0 |
| Non-Operating | ||||||
| Net Interest Expense | -$0 | -$0 | -$0 | -$0 | -$0 | -$0 |
| Other Non-Operating Income (Expense) | $0 | -$0 | -$1 | $0 | $0 | $0 |
| EBT (Earnings Before Tax) | $0 | -$0 | -$1 | -$0 | -$0 | -$0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Earnings from Continuing Ops | — | — | — | — | — | -$0 |
| Net Income | ||||||
| Net Income | $0 | -$0 | -$1 | -$0 | -$0 | -$0 |
| Per Share Data | ||||||
| Revenue Per Share | $0.00 | — | — | — | — | $0.00 |
| EPS (Basic) | $0.00 | -$0.01 | -$0.03 | -$0.01 | -$0.01 | -$0.01 |
| EPS (Diluted) | — | — | — | — | — | -$0.01 |
| Weighted Avg Shares (Basic) | 70.7M | 70.7M | 47.3M | 42.0M | 33.1M | 34.5M |
| Weighted Avg Shares (Diluted) | 208.3M | — | — | — | — | 34.5M |
| Shares Outstanding | 208.3M | — | — | — | — | 34.5M |
Cannabis Suisse (CSUI) generated about n/a in revenue and $107,574.00 in net income (a -2,027.3% net margin) over the trailing twelve months, growing at roughly -37.9% a year. Figures are from SEC filings; this is analysis, not investment advice.
Yes, Cannabis Suisse reported about $107,574.00 in net income over the trailing twelve months, a net profit margin of roughly -2,027.3%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
SourceFinancial statements computed from the 10-Q filed 20 Apr 2026, covering the period ending 28 Feb 2026, as reported to the SEC. Data last refreshed 22 Apr 2026. How this is calculated.
Fiscal year ends May.
Cannabis Suisse runs a gross margin of about 1.9%, an operating margin of about -1,280.1%, a net margin of about -2,027.3%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
Cannabis Suisse's revenue has compounded at roughly -37.9% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside CSUI's margins and free cash flow. This is analysis from SEC filings, not investment advice.